BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 36650482)

  • 21. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
    BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cohort Profile Update: The 45 and Up Study.
    Bleicher K; Summerhayes R; Baynes S; Swarbrick M; Navin Cristina T; Luc H; Dawson G; Cowle A; Dolja-Gore X; McNamara M
    Int J Epidemiol; 2023 Feb; 52(1):e92-e101. PubMed ID: 35604374
    [No Abstract]   [Full Text] [Related]  

  • 24. The impact of the COVID-19 pandemic on cancer care.
    Richards M; Anderson M; Carter P; Ebert BL; Mossialos E
    Nat Cancer; 2020 Jun; 1(6):565-567. PubMed ID: 35121972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal Adenocarcinoma Incidence and Survival Trends in South Australia, 1990-2017.
    Schell D; Ullah S; Brooke-Smith ME; Hollington P; Yeow M; Karapetis CS; Watson DI; Pandol SJ; Roberts CT; Barreto SG
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update.
    Baxter NN; Kennedy EB; Bergsland E; Berlin J; George TJ; Gill S; Gold PJ; Hantel A; Jones L; Lieu C; Mahmoud N; Morris AM; Ruiz-Garcia E; You YN; Meyerhardt JA
    J Clin Oncol; 2022 Mar; 40(8):892-910. PubMed ID: 34936379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia.
    Goldsbury DE; Feletto E; Weber MF; Haywood P; Pearce A; Lew JB; Worthington J; He E; Steinberg J; O'Connell DL; Canfell K
    PLoS One; 2021; 16(11):e0260088. PubMed ID: 34843520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality due to cancer treatment delay: systematic review and meta-analysis.
    Hanna TP; King WD; Thibodeau S; Jalink M; Paulin GA; Harvey-Jones E; O'Sullivan DE; Booth CM; Sullivan R; Aggarwal A
    BMJ; 2020 Nov; 371():m4087. PubMed ID: 33148535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Older adult participation in cancer clinical trials: A systematic review of barriers and interventions.
    Sedrak MS; Freedman RA; Cohen HJ; Muss HB; Jatoi A; Klepin HD; Wildes TM; Le-Rademacher JG; Kimmick GG; Tew WP; George K; Padam S; Liu J; Wong AR; Lynch A; Djulbegovic B; Mohile SG; Dale W;
    CA Cancer J Clin; 2021 Jan; 71(1):78-92. PubMed ID: 33002206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study.
    Jazieh AR; Akbulut H; Curigliano G; Rogado A; Alsharm AA; Razis ED; Mula-Hussain L; Errihani H; Khattak A; De Guzman RB; Mathias C; Alkaiyat MOF; Jradi H; Rolfo C;
    JCO Glob Oncol; 2020 Sep; 6():1428-1438. PubMed ID: 32986516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
    Araghi M; Arnold M; Rutherford MJ; Guren MG; Cabasag CJ; Bardot A; Ferlay J; Tervonen H; Shack L; Woods RR; Saint-Jacques N; De P; McClure C; Engholm G; Gavin AT; Morgan E; Walsh PM; Jackson C; Porter G; Møller B; Bucher O; Eden M; O'Connell DL; Bray F; Soerjomataram I
    Gut; 2021 Jan; 70(1):114-126. PubMed ID: 32482683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia.
    Worthington J; Feletto E; Lew JB; Broun K; Durkin S; Wakefield M; Grogan P; Harper T; Canfell K
    Public Health; 2020 Feb; 179():90-99. PubMed ID: 31760206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time from diagnosis to treatment of colorectal cancer in a South Australian clinical registry cohort: how it varies and relates to survival.
    Roder D; Karapetis CS; Olver I; Keefe D; Padbury R; Moore J; Joshi R; Wattchow D; Worthley DL; Miller CL; Holden C; Buckley E; Powell K; Buranyi-Trevarton D; Fusco K; Price T
    BMJ Open; 2019 Sep; 9(9):e031421. PubMed ID: 31575579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global patterns and trends in colorectal cancer incidence in young adults.
    Siegel RL; Torre LA; Soerjomataram I; Hayes RB; Bray F; Weber TK; Jemal A
    Gut; 2019 Dec; 68(12):2179-2185. PubMed ID: 31488504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of colorectal cancer.
    Brown KGM; Solomon MJ; Mahon K; O'Shannassy S
    BMJ; 2019 Aug; 366():l4561. PubMed ID: 31439545
    [No Abstract]   [Full Text] [Related]  

  • 36. Trends in Colon and Rectal Cancer Incidence in Australia from 1982 to 2014: Analysis of Data on Over 375,000 Cases.
    Feletto E; Yu XQ; Lew JB; St John DJB; Jenkins MA; Macrae FA; Mahady SE; Canfell K
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):83-90. PubMed ID: 30530848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?
    Semira C; Wong HL; Field K; Lee M; Lee B; Nott L; Shapiro J; Wong R; Tie J; Tran B; Richardson G; Zimet A; Lipton L; Tamjid B; Burge M; Ma B; Johns J; Harold M; Gibbs P
    Intern Med J; 2019 Apr; 49(4):446-454. PubMed ID: 30230679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
    Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
    CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia.
    Lew JB; St John DJB; Macrae FA; Emery JD; Ee HC; Jenkins MA; He E; Grogan P; Caruana M; Greuter MJE; Coupé VMH; Canfell K
    Cancer Epidemiol Biomarkers Prev; 2018 Dec; 27(12):1450-1461. PubMed ID: 30190276
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.